| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.0M | -7.4% |
| Cost of Revenue | $5.1M | -3.7% |
| Gross Profit | $1.8M | -16.2% |
| R&D Expense | $3.5M | +14.9% |
| SG&A Expense | $6.4M | +48.7% |
| Operating Income | -$11.0M | -19.3% |
| Interest Expense | $1.0M | +39.3% |
| Pre-tax Income | -$12.1M | -19.9% |
| Net Income | -$12.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $876K | -18.9% |
| Current Assets | $1.4M | -16.1% |
| Total Assets | $2.3M | -22.6% |
| Current Liabilities | $7.4M | -11.3% |
| Long-term Debt | $7.8M | +47.6% |
| Total Liabilities | $12.8M | +8.0% |
| Stockholders' Equity | -$10.4M | -18.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.1M | -20.6% |
| Capital Expenditures | $16K | -5.4% |
| Investing Cash Flow | -$16K | +46.3% |
| Financing Cash Flow | $8.1M | +25.3% |
| Free Cash Flow | -$8.1M | -20.5% |
| -19.9% |
| EPS (Basic) | -$0.18 | -5.9% |
| EPS (Diluted) | -$0.18 | -5.9% |